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Is it time to re-appraise the role  
of compression in non-healing 
venous leg ulcers?
O Objective: To evaluate the role of compression in non-healing venous leg ulcers (VLUs) 
of > 3 months’ duration.
O Method: Patients’ records from three independent data sets of non-healing VLUs of > 3 months’ 
duration were re-analysed. Two data sets were separate audits of clinical practice and the third comprised 
patients’ records from a randomised controlled trial. Some patients in each data set were never treated 
with compression. The effect of compression on healing at 6 months was tested with logistic regression.
O Results: In each data set, patients in the compression and no-compression groups were matched 
according to ulcer size and duration; there were no differences in comorbidities. Comparing the 
no-compression with the compression groups, the healing rate at 6 months was 68% vs 48% in study 1, 
12% vs 6% in study 2, and 26% vs 11% in study 3. Use of compression was found to be an independent 
predictor of not healing with an odds ratio of 0.422, 0.456 and 0.408 in studies 1, 2 and 3 respectively. 
O Conclusion: The healing rate of non-healing VLUs of > 3 months’ duration in the no-compression 
groups was double that of VLUs in the compression groups. These "ndings have the potential for 
treatment modi"cation if con"rmed in a prospective trial.
O Declaration of interest: There were no external sources of funding for this study. The authors 
have no con#icts of interest that are directly relevant to the content of this manuscript, which remains 
their sole responsibility.
compression; venous leg ulcers; non-healing; UK
 T he management of venous leg ulcers (VLUs) is a signi!cant clinical problem, which imposes huge demands on limited health-care resources.1,2 Venous disease, or chronic venous insuf!ciency (CVI), is the 
result of ongoing pooling and congestion of venous 
blood. This may be due to a number of features 
including, but not limited to, varicosities, obesity 
and calf muscle pump impairment. The congestion 
of blood in the deep veins increases ambulatory pres-
sures and results in venous hypertension, which sub-
sequently increases the hydrostatic pressure in the 
super!cial veins. This alteration in pressure dynamics 
leads to capillary "uid loss and soft tissue oedema.
Venous pressure in a standing individual is largely 
hydrostatic;3 hence, the external pressure necessary to 
counteract this effect progressively reduces up the leg, 
as the hydrostatic head is effectively reduced.3 Conse-
quently, external compression is usually applied to a 
VLU in a graduated fashion, with the highest pressure 
at the ankle and reducing below the knee.3,4
The application of graduated external compres-
sion has been shown to minimise or reverse the 
vascular changes that occur in a VLU, by forcing 
"uid from the interstitial spaces back into the vascu-
lar and lymphatic compartments.4 However, there is 
less agreement about the precise level of pressure 
required. Pressures of about 40mmHg at the ankle 
are widely quoted in the literature for the preven-
tion or treatment of VLUs, but some recommend 
values signi!cantly higher than this.4–6
In clinical practice, the optimum pressure varies 
according to a number of factors, including the 
severity of the wound and the height and limb size 
of the patient. The majority of newly-presenting 
VLUs can be induced to heal by applying adequate 
levels of sustained, graduated compression.7 In such 
situations compression bandages currently repre-
sent the treatment of choice.
Several different types of compression bandaging 
systems are available, each of which may have advan-
tages over the others for particular applications. 
Moreover, they vary greatly in their ability to provide 
sustained compression, owing to differences in their 
structure and content of elastomeric yarns.4 Other 
factors, such as limb circumference and shape, also 
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affect the pressure produced beneath a compression 
bandage.4 However, there is some anecdotal evidence 
that nurses in the community have dif!culty deter-
mining which type to apply. 
High compression bandaging (30–40mmHg) is an 
effective treatment, healing over 70% of uncompli-
cated VLUs in 3 months.5,6 A systematic review of 
different compression bandages for VLUs concluded 
that the rate of ulcer healing was increased with 
compression bandages compared with no compres-
sion.4 It also found multicomponent compression 
systems more effective than single-component 
systems, and those with elastic bandages were more 
effective than inelastic systems. However, there 
were no clear differences in the effectiveness of 
different types of high compression.4
We recently conducted a study on > 400 highly-
exuding VLUs of ≥ 3  months’ duration using 
patients’ records from The Health Improvement 
Network (THIN) database, a nationally representa-
tive database of patients registered with general 
practitioners (GPs) in the UK.8 Surprisingly, we 
found that 20% of the wounds were never treated 
with compression. We then reviewed the data sets 
from two other chronic VLU analyses9,10 and found 
that > 20% of patients in both studies never 
received any compression. 
The aim of this present analysis was to elucidate 
the effect of no compression on wound healing and 
wound-size reduction in these patients with chronic 
wounds of ≥ 3 months’ duration.
Method
Study 1
The THIN database contains computerised informa-
tion on > 9 million anonymised patients entered by 
GPs from 500  practices across the UK.11 General 
practices across the UK using Vision Practice 
Management Software are invited to participate in 
the database, and are self-selecting. The patient data 
within THIN has been shown to be representative of 
the UK population in terms of demographics and 
disease distribution.12,13
Information contained in the THIN database 
includes patients’ demographics, details from GP 
consultations, specialist referrals, nurse and other cli-
nician visits, hospital admissions, diagnostic and 
therapeutic procedures, laboratory tests and prescrip-
tions issued by GPs, which are directly generated by 
the general practice’s IT system. The information 
contained in the THIN database re"ects real clinical 
practice, as it is based on actual patient records. 
Moreover, GPs are the gatekeepers to health care in 
the UK, and patients’ entire medical history is theo-
retically stored in their primary-care record. 
The anonymised records of a randomised sample 
of 414  patients in the THIN database, who were 
treated with one of !ve absorbent dressings for their 
VLU between 1  January 2010 and 30  June 2011, 
were analysed. To be included in the data set, 
patients had to have been 18 years of age or over, 
had one of the following read codes for a VLU: 
14F5.00 H/O, M271500 or G837.000, had their VLU 
for at least 3  months before treatment with an 
absorbent dressing and had at least 6 months’ fol-
low-up data in their case record following the start 
of treatment with an absorbent dressing. Patients in 
the !ve groups were matched according to age, gen-
der, their general practice, date of diagnosis of their 
VLU and treatment start date.8
Twenty per cent (n=82) of these patients never 
received any compression. Those who died or had 
missing data were excluded from the sample, yield-
ing 74  patients who never received compression. 
These patients were then matched with 74 patients 
who received compression based on:
O The time with their VLU before treatment with an 
absorbent dressing
O The initial VLU size at treatment start date.
Study 2
The population of study 2 was also extracted from 
the THIN database. It comprised the anonymised 
records of 255 patients who were treated with a skin 
protectant for their VLU between 1  January 2008 
and 31  December 2009 and the records of 255 
matched patients who never received a skin protect-
ant for their VLU over the same period. To be 
included in the data set, patients had to have been 
18 years of age or over, had one of the following 
Read codes for a VLU: 14F5.00 H/O, M271500 or 
G837.000 and had at least 6 months’ follow-up data 
in their case record following treatment with a skin 
protectant or the matched start date. Patients in the 
two groups were matched according to age, gender, 
the general practice where they were treated and the 
date of diagnosis of their VLU.9
Thirty two per cent (n=164) of these patients nev-
er received any compression. These patients were 
then matched with 164 patients who received com-
pression based on:
O The time with their VLU before the study start 
date
O The initial VLU size at treatment start date.
Study 3
The population of study 3 comprised the anonymised 
records of patients who participated in a multi-cen-
tred, controlled clinical trial, which was conducted in 
2005/2006. Patients with a chronic VLU were ran-
domised to receive either an advanced topical treat-
ment (amelogenin [Xelma; Mölnlycke]) combined 
with standard dressings, or standard dressings alone. 
Patients were followed-up weekly for 3 months with 
one follow-up assessment at 6 months in a hospital 
clinic.10 To be included in the study, a patient’s ulcer 
practice
J O U R N A L  O F  WO U N D  C A R E   VO L  2 2 , N O  9 , S E P T E M B E R  2 0 1 34 5 6
©
 2
0
1
3
 M
A
 H
E
A
L
T
H
C
A
R
E
 L
T
D
had to be at least 6 months old, have a surface area of 
10–30cm2 and not demonstrate excessive exudate or 
signs of infection. All patients were meant to have 
received high compression bandaging one month 
before and during the 3-week run-in period, although 
this cannot be veri!ed.10
Eighty three patients were recruited into the study 
of which 23% (n=19) seemed to have never received 
any compression during the trial. The 19  patients 
who never received any compression were matched 
with 19 patients who received compression based on:
O The time with their VLU before recruitment into 
the trial
O The initial VLU size at the start of the trial.
Data analysis
For studies 1 and 2, the following information was 
extracted from patients’ records: age, gender, symp-
toms, comorbidities and duration of symptoms, and 
community-based and secondary-care VLU-related 
resource use over a period of 6 months following 
the treatment start date. Speci!c wound size esti-
mates for all patients were not available for every 
dressing change. In those instances, patients’ wound 
size was estimated to be 80% of the size of the pri-
mary dressing, as previously described.8,9
For study  3, the following information was 
extracted from patients’ clinical trial case report 
forms: age, gender, symptoms, comorbidities and 
duration of symptoms, health-care resource use 
over a period of 6 months following the trial start 
date. Speci!c wound size estimates were available 
for all patients, using tracings taken and analysed 
with planimetry.10
Patient outcomes were quanti!ed for the compres-
sion and no-compression groups over a 6-month 
follow-up period. Differences between groups were 
tested for statistical signi!cance using a Mann–Whit-
ney U-test or Chi-squared test. Logistic regression 
was performed to identify independent predictors of 
healing. All statistical analyses were performed using 
IBM SPSS Statistics (v21.0; IBM Corporation).
Results
Patients in the compression and no-compression 
groups in each study were well matched in terms of 
their age, gender, duration of wound and initial 
wound size (Table 1). Using a Chi-squared test, no sig-
ni!cant differences in patients’ comorbidities were 
detected between the groups (Table 2). All the patients 
in study 1 had a highly-exuding chronic VLU, where-
as in study 2 only 34% and 38% of patients in the 
compression and no-compression groups, respective-
ly, had a highly-exuding chronic VLU.
Patient management and outcomes 
In studies 1 and 2, patients’ wounds were managed 
in the community by practice nurses or community 
Table 1. Patient characteristics
Study 1 Compression No compression p-value
No. of patients (n)  74  74  N/S
Mean age (years)  74.2 ± 14.4  69.72 ± 17.0  N/S
Female/male  51%/49%  47%/53%  N/S
Mean wound duration (months)  5.8 ± 11.9  5.8 ± 12.1  N/S
Mean initial wound size (cm2)  156.0 ± 158.7  153.3 ± 166.0  N/S
Study 2
No. of patients (n)  164  164  N/S
Mean age (years)  77.0 ± 10.5  76.9 ± 12.2  N/S
Female/male  59%/41%  64%/36%  N/S
Mean wound duration (months)  4.3 ± 7.1  3.1 ± 5.4  N/S
Mean initial wound size (cm2)  95.6 ± 76.1  86.6 ± 64.5  N/S
Study 3
No. of patients (n)  19  19  N/S
Mean age (years)  75.7 ± 9.9  67.4 ± 10.6  N/S
Female/male  79%/21%  68%/32%  N/S
Mean wound duration (months)  30.8 ± 26.6  30.2 ± 26.3  N/S
Mean initial wound size (cm2)  19.9 ± 11.1  18.9 ± 10.4  N/S
Table 2. Patient comorbidities for compression/no compression
Comorbidity (%)   Study 1    Study 2    Study 3 
Cardiovascular 65% 61% 73% 72% 58% 79%
Musculoskeletal 49% 39% 57% 51% 37% 42%
Psychiatric 42% 36% 12% 19% —
Endocrinological/metabolic 30% 34% 30% 37% 21% 16%
Respiratory 18% 15% 18% 22% —
Dermatological 16% 26% 7% 10% 0% 5%
Cancer 14% 20% 15% 14% 5% 11%
Neurological 12% 18% 10% 17% 21% 0%
Gastrointestinal 12% 16% 23% 20% 26% 32%
Peripheral vascular 11% 15% 17% 19% 16% 16%
Genito-urinary 8% 12% 20% 27% 0% 11%
Cerebrovascular 0% 5% 11% 9% < 5% < 5%
Opthalmological < 5% < 5% 12% 14% 0% 5%
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nurses. However, in study 3, patients’ wounds were 
managed in specialist centres by clinical trial inves-
tigators comprising physicians and nurses. 
In study  1, signi!cantly more patients in the 
compression group received an antimicrobial 
dressing, or a hydrogel, foam or soft polymer 
dressing than patients in the no-compression 
group (Table  3). However, every patient in this 
study was prescribed an antibiotic.8 In study  2, 
signi!cantly more patients in the compression 
group received knitted viscose, soft silicone or a 
protease-modulating matrix than patients in the 
no-compression group (Table 3). There were no sig-
ni!cant differences in the use of dressings between 
the two groups in study 3, as this was determined 
by the trial protocol.
Signi!cantly more patients healed in the no-
compression groups than the compression groups 
(Table 4). However, there were no differences in the 
time to healing or the percentage change in wound 
size over 6 months between the groups. Analgesic 
use and antibiotic use differed between the groups, 
which was indicative of the different patient 
cohorts in each study.
Logistic regression showed that use of compres-
sion was an independent predictor of not healing in 
all three studies. The odds ratios (ORs) were 0.422 
(95% con!dence interval [CI]: 0.210; 0.846); 0.456 
(95%CI: 0.239; 0.869) and 0.408 (95%CI: 0.036; 
4.61) in studies 1, 2 and 3, respectively.
Logistic regression also showed that, in study 1, 
the wound duration was an independent predictor 
of not healing (OR: 0.032 [95%CI: 0.032; 0.033] for 
each month). However, healing was not affected by 
a patient’s age, gender or initial wound size. Addi-
tionally, patients receiving compression were more 
likely to require analgesics (OR: 2.48 [95%CI: 1.21; 
5.11]) and antibiotics (OR: 2.43 [95%CI: 1.22; 4.86]), 
over the 6-month study period.
In study  2, a patient’s age was an independent 
predictor of healing (OR: 0.942 [95%CI: 0.919; 
0.966] for each additional year); however, healing 
was not affected by a patient’s gender, level of 
exudate or initial wound size. Patients using 
compression were more likely to use an antibiotic 
over the 6-month study period (OR: 1.34 [95%CI: 
0.94; 2.01]).
In study  3, a patient’s age was an independent 
predictor for the use of compression (OR: 10.98 
[95%CI: 10.08; 11.96] for each additional 10 years). 
However, healing was not affected by a patient’s 
age, gender, length of time with wound or initial 
wound size. Moreover, the healing rate at 6 months 
among amelogenin-treated patients who did not 
receive compression was 44% compared with 11% 
among those who did receive compression.
Among the patients who received compression, 
the VLU healing rate was higher in those using 
class  II hosiery followed by short stretch compres-
sion, class  I compression hosiery, multi-layer 
Table 3. Patients’ use of dressings and compression bandages
    Study 1      Study 2     Study 3
 Compression/ p-value Compression/ p-value Compression/ p-value 
 no compression  no compression  no compression
Dressing (%) 
O Absorbent     56% 43%   N/S    19% 22%   N/S    75% 75%   N/S
O Activated charcoal    4% 3%   N/S    6% 2%   N/S    0% 0%   N/S
O Alginate    8% 13%   N/S    3% 3%   N/S    0% 0%   N/S
O Antimicrobial    51% 25%   < 0.001    15% 9%   N/S    0% 0%   N/S
O Hydrocolloid    5% 13%   N/S    6% 9%   N/S    0% 0%   N/S
O Hydrogel    23% 4%   < 0.001    2% 8%   N/S    0% 0%   N/S
O Impregnated gauze    < 1% < 1%   N/S    1% 3%   N/S    0% 0%   N/S
O Knitted viscose    < 1% < 1%   N/S    13% 3%   < 0.02    0% 0%   N/S
O Low adherence     25% 16%   N/S    < 1% < 1%   N/S    0% 0%   N/S
O Polyurethane foam    32% 16%   < 0.03    14% 23%   N/S    0% 0%   N/S
O Povidone iodine    < 1% < 1%   N/S    3% 6%   N/S    0% 0%   N/S
O Protease modulating matrix    79% 65%   N/S    8% 1%   < 0.05    0% 0%   N/S
O Soft polymer    36% 14%   0.002    3% 10%   N/S    0% 0%   N/S
O Soft silicone    < 1% < 1%   N/S    14% < 1%   < 0.002    50% 50%   N/S
O Vapour-permeable    1% 12%   N/S    < 1% < 1%   N/S    0% 0%   N/S
   "lms and membranes
Compression bandaging (%) 
O Compression hosiery    62% —  —    58% —  —    0% —  —
O Conforming retention bandages    13% —  —    31% —  —    44% —  —
O High compression bandages    5% —  —    10% —  —    29% —  —
O Multi-layer compression    31% —  —    33% —  —    11% —  —
O Short stretch bandages    13% —  —    40% —  —    16% —  —
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compression, conforming retention bandage and 
high-compression bandages (Table 5).
Discussion
The cohorts of patients in these three studies were 
different from one another in terms of their wound 
duration, wound size and the dressings used to 
manage the wounds. Additionally, there were incon-
sistencies between the studies in the levels of exu-
date produced. Nevertheless, in these three distinct 
studies on non-healing VLUs of > 3 months’ dura-
tion proportionally fewer patients healed if they 
received compression compared with those who did 
not receive any compression. The analysis also 
found that the healing rate following use of single-
component compression systems was higher than 
that associated with use of multi-component com-
pression systems. 
These observations may be explained, in part, if 
patients were experiencing popliteal vein incompe-
tence, as this has been reported to be an indicator of 
poor response to compression therapy.14 Addition-
ally, healing of chronic VLUs could be affected by 
an interaction of the haemochromatosis gene poly-
morphism HFE H63D, since the healing of VLUs 
carrying this gene has been shown to be impaired 
by high-strength compression.15 Furthermore, insuf-
!cient arterial supply to the wounds in studies  1 
and 2 cannot be excluded, in which case high levels 
of compression applied to these limbs, or inexpert 
application of bandages, can exacerbate the wound, 
leading to tissue damage.16 Patients in studies  1 
and 2 may have been treated with compression for 
some or all of the time, but this may not have been 
documented in their records. However, even if 
patients did not receive compression, it does not 
imply that the nurses were not attempting to man-
age their patients to the best of their ability. This is 
evidenced to some extent by the dressing choices 
between the compression and no-compression 
groups being different in both studies 1 and 2. 
Notwithstanding this, these observations are 
contrary to the !ndings of a systematic review on 
the use of compression in VLU management.4 
However, the review4 only evaluated controlled 
trials, hence the population in each study is likely 
to be a more homogenous cohort of patients, who 
ful!lled the study’s admission criteria, than that 
seen in clinical practice. Also the follow-up period 
in many of the studies was typically 12 weeks. In 
contrast, two of our studies evaluated a cohort of 
patients managed in clinical practice without any 
exclusion criteria and followed them up for 
6  months. Therefore, clinical effectiveness was 
evaluated at 6 months in clinical practice, rather 
than clinical ef!cacy at 3 months within a control-
led framework. Notwithstanding this, study 3 was 
a multi-centred controlled trial in which patients 
were followed-up for 6 months and the endpoint 
was clinical ef!cacy at that time point, but within 
a controlled framework.
An additional confounding factor is the unknown 
microbiological status of these wounds. Although 
some patients received antimicrobial dressings and/
or systemic antibiotics, the authors were unable to 
comment on the need for, or the speci!c impact of, 
these interventions on individual wounds and their 
healing/non-healing status. The science under-
pinning the level and composition of wound bio-
burden in relation to its impact on healing lacks clar-
ity. In addition, chronic wounds will host bio!lm 
Table 4. Patient outcomes at 6 months
Study 1 Compression No compression p-value
Healed (%)   47%   68% < 0.02
Time to healing (months)*   2.7 ± 1.6   2.0 ± 1.5 N/S
Size of unhealed wounds (cm2)*   144.1 ± 127.3   141.8 ± 121.0 N/S
Percent change in wound size (%)   –8%   –8% N/S
Analgesic use at baseline (%)   46%   24% < 0.01
O Reduction in analgesic use (%)   6%   39% < 0.001
Antibiotic use at baseline (%)   100%   100% N/S 
O Reduction in antibiotic use (%)   30%   51% < 0.01
Study 2
Healed (%)   6%   12% 0.05
Time to healing (months)*   5.3 ± 0.6   4.8 ± 1.0 N/S
Size of unhealed wounds (cm2)*   79.2 ± 53.1   66.3 ± 41.0 < 0.01
Percent change in wound size (%)   –17%   –23% N/S
Analgesic use at baseline (%)   41%   38% N/S
O Reduction in analgesic use (%)   10%   11% N/S
Antibiotic use at baseline (%)   58%   51% N/S 
O Reduction in antibiotic use (%)   47%   50% N/S
Study 3
Healed (%)   11%   26% 0.03
Time to healing (months)*   3.0 ± 1.0   4.4 ± 1.7 N/S
Size of unhealed wounds (cm2)*   22.9 ± 27.0   20.3 ± 20.2 N/S
Percent change in wound size (%)   15%   8% N/S
Analgesic use at baseline (%)   42%   47% N/S
O Reduction in analgesic use (%)   N/A   N/A —
Antibiotic use at baseline   N/A   N/A — 
O Reduction in antibiotic use (%)   N/A   N/A —
 
* Results presented as mean ± standard deviation
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phenotypic bacteria.17 These multispecies bacterial 
communities have been frequently associated with 
delayed healing18 and as their presence in wounds is 
occult and no diagnostic test for bio!lm exists it is 
dif!cult to directly attribute (other than a potential 
for delayed healing) the clinical implications of bio-
!lm presence to the VLUs included in this study. 
Limitations
This analysis has a number of limitations. The studies 
were not powered to detect the effect of no compres-
sion. Hence, these studies have < 80% power to detect 
signi!cant differences with a type I (alpha) error of 
0.05 between the two groups. The results were cen-
sored at 6 months and exclude the consequences of 
managing patients beyond this period. The analysis 
only considered the ‘average patient’ and no attempt 
was made to stratify the results according to gender, 
comorbidities, suitability of patients for different 
treatments and other disease-related factors. The 
uncertainty surrounding the microbiological status 
of the wounds is an additional study limitation. This 
is an unaccounted-for variable where the status of 
the wound bioburden will have an unknown positive 
or negative impact whether or not the patients 
received compression. 
There are many outcomes that could be used 
to assess the effect of an intervention on a 
wound including wound healing, wound-size 
reduction, granulation, exudate reduction and 
epithelialisation. However, in studies 1 and 2 the 
records in the THIN database did not include all of 
this information for all patients. Reduction in 
wound surface area was the only outcome that 
could be estimated from all the patients’ records. 
In study  3, wound surface area was measured at 
each dressing change. Hence, reduction in wound 
surface area was the metric used to assess the effect 
of no compression.
As study  3 was a controlled trial, compression 
should have been applied correctly by the clinical 
investigators. However, studies  1 and  2 are an 
assessment of actual clinical practice in which 
compression was applied in the community by 
practice nurses and community nurses; therefore, 
it is questionable whether therapeutic levels of 
compression would have been consistently applied 
at all times. Indeed, it has been reported that 
the effectiveness of compression is likely to be 
in"uenced by the ability of those applying the 
bandage to generate safe levels of compression and 
by the !tting of appropriately sized compression 
stockings or leggings.16
Nevertheless, this analysis provides a provisional 
assessment of the clinical outcomes attributable to 
compression versus no compression. While the 
study results are surprising and compelling, the 
analyses were based on clinicians’ entries into their 
patients’ records and may be subject to a certain 
amount of imprecision and lack of detail. Moreover, 
the computerised information in the THIN database 
is collected by GPs for the purposes of clinical care 
for their patients and not for research purposes. 
Hence, some information may be required for 
research purposes that was not recorded since it was 
not required for clinical reasons. 
This analysis raises the questions of whether the 
!ndings re"ect:
O Correct use of compression bandaging?
O Improper use of compression bandaging?
O In"uence of dressings under compression?
O Patient concordance?
O Lack of training among nurses?
O Lack of continuity/consistency of care of patients 
between clinicians at each dressing change?
O Differential effects between compression systems?
O Lack of mobility among patients treated with 
compression?
O Correct differential diagnosis of VLUs, or do some 
of these ulcers have an arterial involvement? 
This study’s observations now need to be eval-
uated in a controlled trial comparing no compres-
sion with different compression systems in patients 
with a non-healing VLU of > 3 months’ duration 
in which wound size, infection, healing and 
other clinical outcome measures, health-related 
quality of life and cost-effectiveness metrics are 
measured prospectively. Our observations have the 
potential for treatment modi!cation, if con!rmed 
in a prospective trial.
Conclusion
The healing rate of non-healing VLUs of > 3 months’ 
duration in the no-compression groups was double 
that of VLUs in the compression groups. These !nd-
ings have the potential for treatment modi!cation 
if con!rmed in a prospective trial. Q
Table 5. Healing rate of different compression systems 
as a proportion of the healing rate in the no-compression group 
in each study
 Study 1 Study 2 Study 3 Mean 
 (n=332) (n=346) (n=64)
Class 2 compression hosiery 0.87 0.50 N/A 0.68
Short-stretch compression bandage 0.49 0.08 0.77 0.45
Class 1 compression hosiery 0.46 0.25 N/A 0.35
Multi-layer compression 0.40 0.08 0.58 0.35
Conforming retention bandage 0.28 0.00 0.38 0.22
High compression bandage 0.00 0.00 0.31 0.10
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Commentary
Should we forget 
compression therapy in 
long-standing, recalcitrant 
venous leg ulcers?
 Following the data presented by Julian Guest et al. this question is open for 
discussion. At least in a real-life 
scenario, with predominantly 
old patients (mean age 
> 70 years) suffering from many 
comorbidities and with the large 
majority being treated by staff 
who are not speci!cally trained, 
the authors have demonstrated 
that different compression 
modalities may cause more  
harm than bene!t.
My usual suggestions in a 
patient whose leg ulcer does not 
show improvement after 4 weeks 
of compression are:
O Reconsider the diagnosis 
‘venous ulcer’ and rule out 
potential additional pathologies 
(such as arterial occlusions)
O Check the quality of 
compression therapy.
These two points could also be 
crucial for explaining the 
unexpected results reported here:
At least in non-specialised 
centres, the diagnosis of ‘venous’ 
leg ulcer is usually made by 
exclusion of other underlying 
disease. Venous pathology, which 
is the main target of compression 
therapy, is rarely veri!ed  
(by Duplex ultrasound) and even 
concomitant arterial occlusive 
disease may frequently be 
overlooked. In the above  
article, studies 1 and 2 seem to  
fall into this category.
Even more important is the 
quality of the compression 
therapy that has been used.
In studies 1 and 2, compression 
hosiery was applied in the 
majority of cases (62% and 58%, 
respectively), a rather disputable 
form of management in patients 
over 70 years old with large leg 
ulcers (mean size ≥ 10×10cm), 
especially concerning 
applicability and concordance. 
However, it is amazing to see 
that, in study 1 after 6 months, 
47% of these large ulcers were 
healed with compression and 
68% without compression. The 
fact that such large ulcers, active 
for a mean duration of 
5.8 months, were healed 
6 months later just by local 
dressings comes close to a 
miracle. Maybe the antibiotics 
given to all patients in this study 
had a positive in"uence. Since 
the routine application of 
antibiotics in leg ulcers is not 
recommended in modern 
guidelines, this could be one issue 
to be investigated more closely in 
the future. Interestingly, much 
less favourable outcomes are 
demonstrated in study 2, despite 
similar baseline conditions, with 
healing rates after 6 months  
of only 6% in the compression 
group and 12% without 
compression.
In study 3, based on a 
randomised controlled trial 
(RCT) performed in a specialised 
centre, which compared different 
local dressings, 44% of the  
ulcers received ‘conforming 
retention bandages’ and 29% 
‘high-compression bandages’. 
After 6 months, 26% were healed 
without but only 11% with 
compression. While the healing 
rate without compression comes 
close to recently-published data 
from an RCT,1 the signi!cantly 
worse result with compression 
shows that the chosen forms  
of compression have caused 
damage in a considerable  
portion of patients.
We are grateful to the authors 
for their article pointing to the 
challenge of treating recalcitrant 
leg ulcers in elderly patients in 
the community. The most 
important issue would be to 
avoid, or at least to reduce, the 
number of recalcitrant ulcers by 
early intervention targeted at 
re"ux abolition and by adequate 
compression. In general, I believe 
that most non-healing ulcers are 
due to inadequate care, mainly 
because of poor compression.
So my answer to the initial 
question is clear: NO, we need 
compression therapy since we 
cannot escape from gravity. But 
there is a need for better 
knowledge of effective forms of 
compression to counteract gravity 
and especially better skills in 
performing proper bandaging 
learned and trained in quali!ed 
hands on courses, in order to 
improve the regrettable real life 
situation re"ected in the article. 
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